awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38859473-037B2B9D-289F-40FF-8CE5-0FFF4B65F4AD
Q38859473-037B2B9D-289F-40FF-8CE5-0FFF4B65F4AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38859473-037B2B9D-289F-40FF-8CE5-0FFF4B65F4AD
Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence.
P2860
Q38859473-037B2B9D-289F-40FF-8CE5-0FFF4B65F4AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38859473-037B2B9D-289F-40FF-8CE5-0FFF4B65F4AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91a1495ca86512f2cf3ef0a79caaa4a722577f69
P2860
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.